Charles Schwab’s Spero Therapeutics SPRO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $82.8K | Hold |
28,565
| – | – | ﹤0.01% | 3422 |
|
2025
Q1 | $20.6K | Hold |
28,565
| – | – | ﹤0.01% | 3461 |
|
2024
Q4 | $29.4K | Hold |
28,565
| – | – | ﹤0.01% | 3473 |
|
2024
Q3 | $38.3K | Hold |
28,565
| – | – | ﹤0.01% | 3440 |
|
2024
Q2 | $37.1K | Hold |
28,565
| – | – | ﹤0.01% | 3546 |
|
2024
Q1 | $49.1K | Hold |
28,565
| – | – | ﹤0.01% | 3371 |
|
2023
Q4 | $42K | Hold |
28,565
| – | – | ﹤0.01% | 3417 |
|
2023
Q3 | $34.6K | Hold |
28,565
| – | – | ﹤0.01% | 3443 |
|
2023
Q2 | $41.4K | Hold |
28,565
| – | – | ﹤0.01% | 3440 |
|
2023
Q1 | $41.4K | Hold |
28,565
| – | – | ﹤0.01% | 3380 |
|
2022
Q4 | $49.4K | Buy |
+28,565
| New | +$49.4K | ﹤0.01% | 3363 |
|
2022
Q2 | – | Sell |
-65,547
| Closed | -$571K | – | 3635 |
|
2022
Q1 | $571K | Hold |
65,547
| – | – | ﹤0.01% | 3061 |
|
2021
Q4 | $1.05M | Buy |
65,547
+1,961
| +3% | +$31.4K | ﹤0.01% | 2895 |
|
2021
Q3 | $1.17M | Buy |
63,586
+3,090
| +5% | +$56.9K | ﹤0.01% | 2816 |
|
2021
Q2 | $845K | Buy |
60,496
+7,138
| +13% | +$99.7K | ﹤0.01% | 2991 |
|
2021
Q1 | $786K | Buy |
53,358
+1,527
| +3% | +$22.5K | ﹤0.01% | 2929 |
|
2020
Q4 | $1.01M | Buy |
51,831
+16,377
| +46% | +$318K | ﹤0.01% | 2766 |
|
2020
Q3 | $396K | Hold |
35,454
| – | – | ﹤0.01% | 2949 |
|
2020
Q2 | $480K | Buy |
35,454
+4,090
| +13% | +$55.4K | ﹤0.01% | 2846 |
|
2020
Q1 | $254K | Buy |
31,364
+4,138
| +15% | +$33.5K | ﹤0.01% | 2941 |
|
2019
Q4 | $262K | Hold |
27,226
| – | – | ﹤0.01% | 3001 |
|
2019
Q3 | $289K | Buy |
27,226
+2,108
| +8% | +$22.4K | ﹤0.01% | 2972 |
|
2019
Q2 | $290K | Buy |
25,118
+5,895
| +31% | +$68.1K | ﹤0.01% | 3023 |
|
2019
Q1 | $247K | Buy |
19,223
+4,696
| +32% | +$60.3K | ﹤0.01% | 2979 |
|
2018
Q4 | $90K | Hold |
14,527
| – | – | ﹤0.01% | 3097 |
|
2018
Q3 | $153K | Buy |
+14,527
| New | +$153K | ﹤0.01% | 3099 |
|